title: Fingolimod-associated PML in a patient with prior immunosuppression.
authors.affiliation: From the University of Rochester Medical Center, Rochester, NY. Tirisham_Gyang@urmc.rochester.edu.
authors.forename: Tirisham V
authors.initials: TV
authors.lastname: Gyang
authors.affiliation: From the University of Rochester Medical Center, Rochester, NY.
authors.forename: Johanna
authors.initials: J
authors.lastname: Hamel
authors.affiliation: From the University of Rochester Medical Center, Rochester, NY.
authors.forename: Andrew D
authors.initials: AD
authors.lastname: Goodman
authors.affiliation: From the University of Rochester Medical Center, Rochester, NY.
authors.forename: Robert A
authors.initials: RA
authors.lastname: Gross
authors.affiliation: From the University of Rochester Medical Center, Rochester, NY.
authors.forename: Lawrence
authors.initials: L
authors.lastname: Samkoff
mesh_terms: D005260:Female; D000068876:Fingolimod Hydrochloride / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007968:Leukoencephalopathy, Progressive Multifocal / Q000209:etiology*; D008875:Middle Aged; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*
chemical_list: D007166:Immunosuppressive Agents; D000068876:Fingolimod Hydrochloride